Perimeter CEO Discusses Future of Biological Engineering
Perimeter CEO Matthew Fox McKnight describes the company's market view and its position within the era of biological engineering, which he identifies as the next scientific revolution.
Matthew Fox McKnight, Chief Executive Officer of Perimeter, has outlined the company's perspective on its market and its role in the evolving field of biological engineering in an interview with CB Insights. Mcknight draws parallels between the current advancements in biological engineering and historical scientific revolutions, including chemistry in the early 1900s, physics in the 1930s, and the advent of the computer chip in the 1950s and 60s. He stated that the era of biological engineering, transitioning from theoretical to practical applications, began around 2015. Perimeter aims to capitalize on this scientific shift, positioning itself as a key player in the emerging biological engineering landscape. The company is focused on addressing market demands and customer needs by leveraging the capabilities of this new engineering discipline. According to McKnight, recent technological progress has enabled a deeper understanding and manipulation of complex biological systems, opening up new possibilities across various sectors, including medicine and materials science. The company continues to focus on its market insights and customer requirements to navigate the rapidly advancing scientific domain effectively.